Share Price and Basic Stock Data
Last Updated: January 14, 2026, 8:17 pm
| PEG Ratio | 0.85 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
20 Microns Ltd, operating in the mining and minerals sector, reported a share price of ₹192 and a market capitalization of ₹676 Cr. The company has demonstrated consistent revenue growth, with sales increasing from ₹613 Cr in FY 2022 to ₹702 Cr in FY 2023, and projected to reach ₹777 Cr in FY 2024 and ₹913 Cr in FY 2025. In the most recent quarter (Sep 2023), sales stood at ₹200 Cr, reflecting a robust upward trajectory as compared to ₹188 Cr in Sep 2022. The quarterly sales figures indicate a strong momentum, with sequential growth observed in subsequent quarters, culminating in ₹240 Cr expected by Sep 2024. This growth trajectory aligns with the overall demand in the mining sector, driven by infrastructure development and industrial activities. The company’s ability to maintain this growth will depend on market conditions and operational efficiencies.
Profitability and Efficiency Metrics
20 Microns Ltd reported a net profit of ₹62 Cr for FY 2025, up from ₹42 Cr in FY 2023, demonstrating a notable improvement in profitability. The operating profit margin (OPM) stood at 13% for FY 2025, slightly declining from 14% in FY 2024, yet remaining competitive within the industry. The company’s return on equity (ROE) was 16.3%, while return on capital employed (ROCE) reached 19.2%, indicating effective utilization of equity and capital. The interest coverage ratio (ICR) of 6.67x showcases the company’s ability to meet its interest obligations comfortably. However, the cash conversion cycle (CCC) of 126 days indicates operational inefficiencies that could affect liquidity. The profitability ratios reflect a solid operational framework, but the company must address its CCC to enhance cash flow management.
Balance Sheet Strength and Financial Ratios
As of FY 2025, 20 Microns Ltd reported total assets of ₹715 Cr, with total liabilities at ₹715 Cr as well, reflecting a balanced sheet structure. The company’s reserves have increased to ₹437 Cr, up from ₹276 Cr in FY 2023, highlighting a strong retention of earnings. Borrowings stood at ₹163 Cr, with a low long-term debt to equity ratio of 0.05, suggesting minimal reliance on debt for financing. The current ratio of 1.71 indicates sufficient short-term liquidity to meet obligations. However, the price-to-book value (P/BV) ratio of 1.57x is on the higher side compared to typical sector norms, potentially indicating overvaluation concerns. The company’s balance sheet reflects stability and growth potential, yet the elevated P/BV warrants caution for potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of 20 Microns Ltd indicates a significant public ownership of 54.52%, with promoters holding 45.04% as of Sep 2025. The presence of institutional investors remains minimal, with foreign institutional investors (FIIs) at 0.26% and domestic institutional investors (DIIs) at 0.17%. The number of shareholders has increased to 38,301, suggesting growing interest among retail investors. Despite the stability in promoter holding, the low institutional stake may reflect cautious sentiment regarding the company’s market performance and operational challenges. The company’s ability to attract institutional interest could enhance its credibility and support share price stability. Increased transparency and performance metrics could bolster investor confidence moving forward.
Outlook, Risks, and Final Insight
20 Microns Ltd faces a promising outlook, bolstered by its consistent revenue growth and profitability metrics. However, the company must navigate several risks, including operational inefficiencies reflected in its cash conversion cycle and a high P/BV ratio that may deter value-oriented investors. Additionally, the mining sector is subject to regulatory changes and market fluctuations, which could impact future performance. The company should focus on improving operational efficiencies and enhancing liquidity to mitigate these risks. In the event of successful execution of its growth strategy and operational improvements, 20 Microns Ltd could solidify its market position. Conversely, failure to address these risks may hinder growth and profitability, underscoring the importance of strategic management in navigating the competitive landscape. Overall, the company presents a balanced risk-reward scenario for potential investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Ganesha Ecoverse Ltd | 66.1 Cr. | 26.9 | 45.0/25.1 | 21.5 | 0.00 % | 7.18 % | 9.49 % | 10.0 | |
| Foundry Fuel Products Ltd | 5.06 Cr. | 6.31 | 7.32/4.83 | 1.66 | 0.00 % | % | % | 10.0 | |
| Deccan Gold Mines Ltd | 2,182 Cr. | 111 | 162/81.2 | 10.3 | 0.00 % | 21.1 % | 14.2 % | 1.00 | |
| Asi Industries Ltd | 246 Cr. | 27.3 | 54.9/25.8 | 9.49 | 38.9 | 1.46 % | 9.88 % | 7.01 % | 1.00 |
| Anmol India Ltd | 76.2 Cr. | 13.4 | 24.7/12.7 | 9.80 | 20.2 | 0.00 % | 9.81 % | 6.70 % | 10.0 |
| Industry Average | 52,147.62 Cr | 606.80 | 17.97 | 97.99 | 1.47% | 19.57% | 16.87% | 5.18 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 188 | 155 | 173 | 191 | 200 | 175 | 212 | 231 | 240 | 215 | 227 | 247 | 231 |
| Expenses | 164 | 138 | 153 | 164 | 170 | 153 | 186 | 201 | 209 | 188 | 199 | 216 | 199 |
| Operating Profit | 23 | 17 | 21 | 26 | 30 | 22 | 27 | 30 | 31 | 26 | 29 | 32 | 32 |
| OPM % | 12% | 11% | 12% | 14% | 15% | 13% | 12% | 13% | 13% | 12% | 13% | 13% | 14% |
| Other Income | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 1 | -0 | 1 | 2 |
| Interest | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | 5 | 5 | 4 |
| Depreciation | 3 | 3 | 4 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | 16 | 10 | 13 | 20 | 22 | 15 | 19 | 24 | 23 | 17 | 19 | 23 | 23 |
| Tax % | 26% | 27% | 29% | 25% | 28% | 25% | 29% | 26% | 27% | 23% | 20% | 26% | 26% |
| Net Profit | 12 | 7 | 9 | 15 | 16 | 12 | 14 | 18 | 16 | 13 | 15 | 17 | 17 |
| EPS in Rs | 3.36 | 2.09 | 2.64 | 4.23 | 4.54 | 3.25 | 3.87 | 5.06 | 4.65 | 3.65 | 4.31 | 4.78 | 4.93 |
Last Updated: January 2, 2026, 4:41 pm
Below is a detailed analysis of the quarterly data for 20 Microns Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 231.00 Cr.. The value appears to be declining and may need further review. It has decreased from 247.00 Cr. (Jun 2025) to 231.00 Cr., marking a decrease of 16.00 Cr..
- For Expenses, as of Sep 2025, the value is 199.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 216.00 Cr. (Jun 2025) to 199.00 Cr., marking a decrease of 17.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 32.00 Cr..
- For OPM %, as of Sep 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Jun 2025) to 14.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Jun 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 23.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 17.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.93. The value appears strong and on an upward trend. It has increased from 4.78 (Jun 2025) to 4.93, marking an increase of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 327 | 356 | 357 | 392 | 427 | 480 | 529 | 484 | 613 | 702 | 777 | 913 | 920 |
| Expenses | 297 | 326 | 310 | 337 | 367 | 411 | 463 | 425 | 534 | 616 | 672 | 796 | 802 |
| Operating Profit | 31 | 30 | 46 | 56 | 60 | 69 | 66 | 59 | 79 | 86 | 106 | 117 | 118 |
| OPM % | 9% | 8% | 13% | 14% | 14% | 14% | 12% | 12% | 13% | 12% | 14% | 13% | 13% |
| Other Income | 2 | 4 | 4 | 2 | 1 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 3 |
| Interest | 24 | 27 | 25 | 24 | 22 | 22 | 22 | 25 | 20 | 18 | 16 | 18 | 19 |
| Depreciation | 11 | 11 | 10 | 10 | 10 | 10 | 13 | 14 | 14 | 14 | 14 | 18 | 20 |
| Profit before tax | -2 | -3 | 14 | 23 | 28 | 38 | 35 | 22 | 48 | 57 | 77 | 83 | 82 |
| Tax % | 19% | -16% | 24% | 31% | 32% | 35% | 30% | -6% | 27% | 27% | 27% | 24% | |
| Net Profit | -2 | -2 | 11 | 16 | 19 | 25 | 24 | 23 | 35 | 42 | 56 | 62 | 62 |
| EPS in Rs | -0.68 | -0.74 | 3.11 | 4.49 | 5.34 | 7.08 | 6.84 | 6.51 | 9.80 | 11.85 | 15.89 | 17.68 | 17.67 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 14% | 0% | 9% | 0% | 0% | 6% | 8% | 7% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 650.00% | 45.45% | 18.75% | 31.58% | -4.00% | -4.17% | 52.17% | 20.00% | 33.33% | 10.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | 650.00% | -604.55% | -26.70% | 12.83% | -35.58% | -0.17% | 56.34% | -32.17% | 13.33% | -22.62% |
20 Microns Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 21% |
| 3 Years: | 23% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 51% |
| 3 Years: | 30% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 16% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: September 4, 2025, 9:45 pm
Balance Sheet
Last Updated: December 4, 2025, 12:52 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 57 | 54 | 70 | 107 | 126 | 150 | 170 | 197 | 234 | 276 | 335 | 412 | 437 |
| Borrowings | 177 | 165 | 163 | 152 | 134 | 124 | 119 | 104 | 123 | 108 | 121 | 165 | 163 |
| Other Liabilities | 77 | 98 | 83 | 86 | 98 | 112 | 137 | 133 | 140 | 121 | 114 | 120 | 123 |
| Total Liabilities | 328 | 333 | 334 | 363 | 376 | 404 | 444 | 452 | 514 | 523 | 588 | 715 | 742 |
| Fixed Assets | 158 | 151 | 151 | 177 | 185 | 195 | 201 | 203 | 207 | 213 | 212 | 284 | 283 |
| CWIP | 9 | 7 | 4 | 7 | 8 | 4 | 11 | 3 | 5 | 8 | 12 | 9 | 21 |
| Investments | 1 | 1 | 1 | 2 | 3 | 4 | 2 | 6 | 9 | 9 | 17 | 25 | 25 |
| Other Assets | 160 | 174 | 178 | 177 | 179 | 201 | 230 | 240 | 293 | 293 | 347 | 396 | 414 |
| Total Assets | 328 | 333 | 334 | 363 | 376 | 404 | 444 | 452 | 514 | 523 | 588 | 715 | 742 |
Below is a detailed analysis of the balance sheet data for 20 Microns Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
- For Reserves, as of Sep 2025, the value is 437.00 Cr.. The value appears strong and on an upward trend. It has increased from 412.00 Cr. (Mar 2025) to 437.00 Cr., marking an increase of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 163.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 165.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 120.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 742.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 715.00 Cr. (Mar 2025) to 742.00 Cr., marking an increase of 27.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 283.00 Cr.. The value appears to be declining and may need further review. It has decreased from 284.00 Cr. (Mar 2025) to 283.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Other Assets, as of Sep 2025, the value is 414.00 Cr.. The value appears strong and on an upward trend. It has increased from 396.00 Cr. (Mar 2025) to 414.00 Cr., marking an increase of 18.00 Cr..
- For Total Assets, as of Sep 2025, the value is 742.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2025) to 742.00 Cr., marking an increase of 27.00 Cr..
Notably, the Reserves (437.00 Cr.) exceed the Borrowings (163.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -146.00 | -135.00 | -117.00 | -96.00 | -74.00 | -55.00 | -53.00 | -45.00 | -44.00 | -22.00 | -15.00 | -48.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 65 | 51 | 57 | 56 | 57 | 53 | 57 | 68 | 60 | 51 | 59 | 57 |
| Inventory Days | 134 | 126 | 150 | 133 | 132 | 134 | 128 | 144 | 148 | 115 | 99 | 120 |
| Days Payable | 112 | 138 | 118 | 105 | 113 | 106 | 115 | 134 | 113 | 79 | 54 | 51 |
| Cash Conversion Cycle | 87 | 39 | 90 | 84 | 77 | 80 | 69 | 78 | 94 | 87 | 104 | 126 |
| Working Capital Days | -47 | -27 | -6 | -4 | 6 | 11 | 18 | 24 | 31 | 34 | 39 | 46 |
| ROCE % | 10% | 9% | 16% | 18% | 19% | 21% | 19% | 15% | 19% | 19% | 22% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 17.68 | 15.89 | 11.85 | 9.80 | 6.51 |
| Diluted EPS (Rs.) | 17.68 | 15.89 | 11.85 | 9.80 | 6.51 |
| Cash EPS (Rs.) | 22.88 | 19.94 | 15.78 | 13.72 | 10.44 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 121.68 | 100.35 | 83.50 | 71.53 | 60.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 121.68 | 100.35 | 83.50 | 71.53 | 60.99 |
| Revenue From Operations / Share (Rs.) | 258.68 | 220.34 | 198.85 | 173.78 | 137.03 |
| PBDIT / Share (Rs.) | 34.33 | 30.95 | 25.13 | 23.11 | 17.29 |
| PBIT / Share (Rs.) | 29.16 | 26.88 | 21.22 | 19.24 | 13.37 |
| PBT / Share (Rs.) | 23.43 | 21.77 | 16.18 | 13.50 | 6.17 |
| Net Profit / Share (Rs.) | 17.71 | 15.87 | 11.87 | 9.85 | 6.52 |
| NP After MI And SOA / Share (Rs.) | 17.68 | 15.89 | 11.85 | 9.80 | 6.51 |
| PBDIT Margin (%) | 13.27 | 14.04 | 12.63 | 13.29 | 12.62 |
| PBIT Margin (%) | 11.27 | 12.19 | 10.66 | 11.07 | 9.76 |
| PBT Margin (%) | 9.05 | 9.88 | 8.13 | 7.76 | 4.50 |
| Net Profit Margin (%) | 6.84 | 7.20 | 5.96 | 5.66 | 4.75 |
| NP After MI And SOA Margin (%) | 6.83 | 7.21 | 5.95 | 5.64 | 4.75 |
| Return on Networth / Equity (%) | 14.52 | 15.88 | 14.24 | 13.75 | 10.71 |
| Return on Capital Employeed (%) | 20.77 | 23.69 | 21.75 | 21.90 | 17.79 |
| Return On Assets (%) | 8.72 | 9.50 | 7.98 | 6.71 | 5.07 |
| Long Term Debt / Equity (X) | 0.05 | 0.03 | 0.06 | 0.11 | 0.11 |
| Total Debt / Equity (X) | 0.35 | 0.32 | 0.34 | 0.47 | 0.40 |
| Asset Turnover Ratio (%) | 1.40 | 1.40 | 1.23 | 1.14 | 1.02 |
| Current Ratio (X) | 1.71 | 1.75 | 1.53 | 1.33 | 1.23 |
| Quick Ratio (X) | 0.98 | 1.16 | 0.88 | 0.70 | 0.68 |
| Inventory Turnover Ratio (X) | 6.70 | 3.65 | 2.92 | 2.85 | 2.63 |
| Dividend Payout Ratio (NP) (%) | 7.07 | 4.72 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.47 | 3.75 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 92.93 | 95.28 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.53 | 96.25 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 6.67 | 6.63 | 4.99 | 4.03 | 2.40 |
| Interest Coverage Ratio (Post Tax) (X) | 4.55 | 4.50 | 3.36 | 2.72 | 1.90 |
| Enterprise Value (Cr.) | 791.16 | 563.53 | 334.96 | 365.34 | 200.94 |
| EV / Net Operating Revenue (X) | 0.86 | 0.72 | 0.47 | 0.59 | 0.41 |
| EV / EBITDA (X) | 6.53 | 5.16 | 3.78 | 4.48 | 3.29 |
| MarketCap / Net Operating Revenue (X) | 0.74 | 0.65 | 0.37 | 0.42 | 0.25 |
| Retention Ratios (%) | 92.92 | 95.27 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.57 | 1.44 | 0.89 | 1.04 | 0.57 |
| Price / Net Operating Revenue (X) | 0.74 | 0.65 | 0.37 | 0.42 | 0.25 |
| EarningsYield | 0.09 | 0.11 | 0.15 | 0.13 | 0.18 |
After reviewing the key financial ratios for 20 Microns Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 22.88. This value is within the healthy range. It has increased from 19.94 (Mar 24) to 22.88, marking an increase of 2.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 121.68. It has increased from 100.35 (Mar 24) to 121.68, marking an increase of 21.33.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 121.68. It has increased from 100.35 (Mar 24) to 121.68, marking an increase of 21.33.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 258.68. It has increased from 220.34 (Mar 24) to 258.68, marking an increase of 38.34.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 34.33. This value is within the healthy range. It has increased from 30.95 (Mar 24) to 34.33, marking an increase of 3.38.
- For PBIT / Share (Rs.), as of Mar 25, the value is 29.16. This value is within the healthy range. It has increased from 26.88 (Mar 24) to 29.16, marking an increase of 2.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.43. This value is within the healthy range. It has increased from 21.77 (Mar 24) to 23.43, marking an increase of 1.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.71. This value is within the healthy range. It has increased from 15.87 (Mar 24) to 17.71, marking an increase of 1.84.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has increased from 15.89 (Mar 24) to 17.68, marking an increase of 1.79.
- For PBDIT Margin (%), as of Mar 25, the value is 13.27. This value is within the healthy range. It has decreased from 14.04 (Mar 24) to 13.27, marking a decrease of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 11.27. This value is within the healthy range. It has decreased from 12.19 (Mar 24) to 11.27, marking a decrease of 0.92.
- For PBT Margin (%), as of Mar 25, the value is 9.05. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 9.05, marking a decrease of 0.83.
- For Net Profit Margin (%), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 7.20 (Mar 24) to 6.84, marking a decrease of 0.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.83. This value is below the healthy minimum of 8. It has decreased from 7.21 (Mar 24) to 6.83, marking a decrease of 0.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.52. This value is below the healthy minimum of 15. It has decreased from 15.88 (Mar 24) to 14.52, marking a decrease of 1.36.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.77. This value is within the healthy range. It has decreased from 23.69 (Mar 24) to 20.77, marking a decrease of 2.92.
- For Return On Assets (%), as of Mar 25, the value is 8.72. This value is within the healthy range. It has decreased from 9.50 (Mar 24) to 8.72, marking a decrease of 0.78.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.35, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.40. There is no change compared to the previous period (Mar 24) which recorded 1.40.
- For Current Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.71, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.98, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.70. This value is within the healthy range. It has increased from 3.65 (Mar 24) to 6.70, marking an increase of 3.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.07. This value is below the healthy minimum of 20. It has increased from 4.72 (Mar 24) to 7.07, marking an increase of 2.35.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 20. It has increased from 3.75 (Mar 24) to 5.47, marking an increase of 1.72.
- For Earning Retention Ratio (%), as of Mar 25, the value is 92.93. This value exceeds the healthy maximum of 70. It has decreased from 95.28 (Mar 24) to 92.93, marking a decrease of 2.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.53. This value exceeds the healthy maximum of 70. It has decreased from 96.25 (Mar 24) to 94.53, marking a decrease of 1.72.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.67. This value is within the healthy range. It has increased from 6.63 (Mar 24) to 6.67, marking an increase of 0.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.55. This value is within the healthy range. It has increased from 4.50 (Mar 24) to 4.55, marking an increase of 0.05.
- For Enterprise Value (Cr.), as of Mar 25, the value is 791.16. It has increased from 563.53 (Mar 24) to 791.16, marking an increase of 227.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.86, marking an increase of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 6.53. This value is within the healthy range. It has increased from 5.16 (Mar 24) to 6.53, marking an increase of 1.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.74, marking an increase of 0.09.
- For Retention Ratios (%), as of Mar 25, the value is 92.92. This value exceeds the healthy maximum of 70. It has decreased from 95.27 (Mar 24) to 92.92, marking a decrease of 2.35.
- For Price / BV (X), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 1.57, marking an increase of 0.13.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.74, marking an increase of 0.09.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.09, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 20 Microns Ltd:
- Net Profit Margin: 6.84%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.77% (Industry Average ROCE: 19.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.52% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.55
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.6 (Industry average Stock P/E: 17.97)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.35
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.84%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Mining/Minerals | 9/10, GIDC Industrial Estate, Waghodia, Vadodra District Gujarat 391760 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh C Parikh | Chairman & Managing Director |
| Mr. Atil C Parikh | Managing Director & CEO |
| Mrs. Sejal R Parikh | Whole Time Director |
| Dr. Ajay I Ranka | Independent Director |
| Mr. Jaideep B Verma | Independent Director |
| Dr. Sivaram Swaminathan | Independent Director |
| Mr. Dukhabandhu Rath | Independent Director |
| Mr. Prem Kumar Taneja | Additional Director |
FAQ
What is the intrinsic value of 20 Microns Ltd?
20 Microns Ltd's intrinsic value (as of 14 January 2026) is ₹179.49 which is 5.53% lower the current market price of ₹190.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹670 Cr. market cap, FY2025-2026 high/low of ₹284/158, reserves of ₹437 Cr, and liabilities of ₹742 Cr.
What is the Market Cap of 20 Microns Ltd?
The Market Cap of 20 Microns Ltd is 670 Cr..
What is the current Stock Price of 20 Microns Ltd as on 14 January 2026?
The current stock price of 20 Microns Ltd as on 14 January 2026 is ₹190.
What is the High / Low of 20 Microns Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of 20 Microns Ltd stocks is ₹284/158.
What is the Stock P/E of 20 Microns Ltd?
The Stock P/E of 20 Microns Ltd is 10.6.
What is the Book Value of 20 Microns Ltd?
The Book Value of 20 Microns Ltd is 129.
What is the Dividend Yield of 20 Microns Ltd?
The Dividend Yield of 20 Microns Ltd is 0.66 %.
What is the ROCE of 20 Microns Ltd?
The ROCE of 20 Microns Ltd is 19.2 %.
What is the ROE of 20 Microns Ltd?
The ROE of 20 Microns Ltd is 16.3 %.
What is the Face Value of 20 Microns Ltd?
The Face Value of 20 Microns Ltd is 5.00.